Diseases of the Abdomen and Pelvis 2023-2026 : : Diagnostic Imaging.
Saved in:
Superior document: | IDKD Springer Series |
---|---|
: | |
TeilnehmendeR: | |
Place / Publishing House: | Cham : : Springer International Publishing AG,, 2023. ©2023. |
Year of Publication: | 2023 |
Edition: | 1st ed. |
Language: | English |
Series: | IDKD Springer Series
|
Online Access: | |
Physical Description: | 1 online resource (287 pages) |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
5007216788 |
---|---|
ctrlnum |
(MiAaPQ)5007216788 (Au-PeEL)EBL7216788 (OCoLC)1373693615 |
collection |
bib_alma |
record_format |
marc |
spelling |
Hodler, Juerg. Diseases of the Abdomen and Pelvis 2023-2026 : Diagnostic Imaging. 1st ed. Cham : Springer International Publishing AG, 2023. ©2023. 1 online resource (287 pages) text txt rdacontent computer c rdamedia online resource cr rdacarrier IDKD Springer Series Intro -- Contents -- 1: Emergency Radiology of the Abdomen and Pelvis -- 1.1 Trauma Part -- 1.1.1 Role of Imaging to Assess Blunt Abdominal Polytrauma (BAT) Patients -- 1.1.1.1 Primary Survey -- 1.1.1.2 Secondary Survey -- Imaging of Common Abdominal Traumatic Injuries -- Intraperitoneal Fluid -- Organ Injuries -- Spleen Injuries -- Liver Injuries -- Urinary Tract Injuries -- Bowel and Mesenteric Injuries -- Diaphragmatic Injuries -- Pancreatic Injuries -- 1.2 Non-Traumatic Abdominal Pain -- 1.2.1 Modalities -- 1.2.2 Right Upper Quadrant -- 1.2.2.1 Acute Cholecystitis -- 1.2.2.2 Duodenal Ulcers -- 1.2.3 Left Upper Quadrant -- 1.2.3.1 Acute Pancreatitis -- 1.2.3.2 Gastritis -- 1.2.4 Right Lower Quadrant Pain -- 1.2.4.1 Acute Appendicitis -- 1.2.4.2 Cecal Inflammation -- 1.2.4.3 Terminal Ileitis -- 1.2.5 Left Lower Quadrant Pain -- 1.2.5.1 Sigmoid Diverticulitis -- 1.2.5.2 Epiploic Appendagitis -- 1.2.5.3 Pelvic Pain: Endometriosis -- 1.2.5.4 Ovarian Torsion -- 1.2.6 Diffuse Abdominal Pain -- 1.2.6.1 Small Bowel Obstruction -- 1.2.6.2 Colonic Obstruction -- 1.2.6.3 Acute Mesenteric Ischemia -- 1.2.7 Concluding Remarks -- References -- 2: Imaging Infectious Disease of the Abdomen (Including COVID-19) -- 2.1 Introduction -- 2.2 Risk Factors for Infections -- 2.2.1 Barrier Disruption -- 2.2.2 Anatomic Obstruction -- 2.2.3 Vascular Compromise -- 2.2.4 Pre-existing Malignancy -- 2.2.5 Immunosuppression -- 2.2.6 Prior Radiation -- 2.2.7 Medical Devices -- 2.2.8 Surgery -- 2.3 Imaging in Abdominal Infections -- 2.3.1 Gastrointestinal Tract Infections -- 2.3.1.1 Clostridioides Difficile Colitis -- 2.3.1.2 Neutropenic Enterocolitis -- 2.3.1.3 Gastrointestinal Tuberculosis -- 2.3.1.4 Viral Enterocolitis -- 2.3.1.5 Fungal Infections -- 2.3.2 Hepatobiliary Infections -- 2.3.2.1 Liver Abscesses. 2.3.2.2 Cholangitis -- 2.3.2.3 Viral Infections -- 2.3.2.4 Parasitic Infections -- 2.3.3 Genitourinary Tract Infections -- 2.3.3.1 Obstructive Uropathy -- 2.3.3.2 Renal and Urinary Bladder Infections -- 2.3.3.3 Prostatic Infections -- 2.3.4 Peritoneal and Abdominal Wall Infections -- 2.3.4.1 Peritoneal Devices -- 2.3.4.2 Intra-abdominal Abscesses -- 2.3.4.3 Abdominal Wall Infections -- 2.4 Conclusion -- References -- 3: Advances in Molecular Imaging and Therapy and Its Impact in Oncologic Imaging -- 3.1 Introduction -- 3.2 Introduction to Theranostics -- 3.2.1 Therapeutic Radionuclides -- 3.2.2 Unique Role of Dosimetry -- 3.2.3 Current Theranostic Agents and Agents in Development -- 3.2.4 Patient Selection for Internal Radiotherapy -- 3.3 Monitoring Disease -- 3.3.1 Response Based on Morphology -- 3.3.2 Response Based on Morphology for Immunotherapy -- 3.3.3 Response Based on FDG PET -- 3.4 Monitoring Liver Disease After SIRT -- 3.4.1 Monitoring SIRT with CT/MRI -- 3.4.2 Monitoring SIRT with PET -- 3.5 Monitoring Neuroendocrine Tumors -- 3.6 Monitoring Metastasized Prostate Cancer -- 3.6.1 Conventional Monitoring of Metastasized Prostate Cancer with CT and Bone Scans -- 3.6.2 Monitoring Metastasized Prostate Cancer with PET/CT -- 3.7 The Role of MRI and PET/MRI for Response Evaluation -- 3.8 Concluding Remarks -- References -- 4: Benign and Malignant Diseases of the Colon and Rectum -- 4.1 Benign Diseases of the Colon and Rectum -- 4.1.1 Inflammatory Diseases of the Colon and Rectum -- 4.1.1.1 Chronic Inflammatory Bowel Diseases -- 4.1.1.2 Infectious Colitis -- Pseudomembranous Colitis -- 4.1.1.3 Non-infectious Colitis -- Ischemic Colitis -- Drug-Induced Colitis -- Neutropenic Colitis -- Radiation Colitis and Proctitis -- Graft-Versus-Host Disease -- 4.1.2 Diverticular Disease and Diverticulitis. 4.1.3 Benign Mucosal Colonic Polyp -- 4.2 Malignant Diseases of the Colon and Rectum -- 4.2.1 Rectal Cancer -- 4.2.1.1 Elective Rectal Cancer Staging -- 4.2.2 Colon Cancer -- 4.2.2.1 Elective Colon Cancer Staging -- 4.2.2.2 Colon Cancer Presenting as Acute Abdomen -- 4.2.3 Evaluation of Response to Neoadjuvant Therapy in Rectal Cancer -- 4.2.3.1 Technique -- 4.2.3.2 Re-staging to Plan Surgery -- 4.2.3.3 The Prognostic Value of Re-staging MR Imaging -- 4.2.3.4 Re-staging to Select Patients for Non-operative Management -- 4.3 Concluding Remarks -- References -- 5: Indeterminate Retroperitoneal Masses -- 5.1 Introduction -- 5.2 Retroperitoneal Space -- 5.3 Tissue Diagnosis -- 5.4 Adipocytic Tumors -- 5.5 Other Soft-Tissue Sarcomas -- 5.6 Neurogenic Tumors -- 5.7 Miscellaneous -- 5.8 Concluding Remarks -- References -- 6: Diffuse Liver Disease -- 6.1 Metabolic and Storage Diseases -- 6.1.1 Steatosis -- 6.1.2 Iron Overload -- 6.1.3 Wilson's Disease -- 6.1.4 Amyloidosis -- 6.1.5 Gaucher Disease -- 6.2 Cirrhosis -- 6.2.1 Imaging of Pre-stages of Cirrhosis -- 6.2.2 Imaging of Cirrhosis -- 6.3 Focal Lesions in Cirrhotic Liver -- 6.3.1 Regenerative Nodules -- 6.3.2 Dysplastic Nodules -- 6.3.3 Malignant Lesions -- 6.3.4 Confluent Focal Fibrosis -- 6.3.5 Standardized Reporting with LI-RADS -- 6.4 Diffuse Vascular Liver Disease -- 6.4.1 Arteriovenous Shunts -- 6.4.2 Budd-Chiari Syndrome -- 6.4.3 Sinusoidal Obstruction Syndrome -- 6.4.4 Passive Hepatic Congestion and Fontan-Associated Liver Disease -- 6.4.5 Hereditary Hemorrhagic Telangiectasia (HHT) -- 6.5 Diffuse Metastatic Disease -- 6.6 Concluding Remarks -- References -- 7: Focal Liver Lesions -- 7.1 Introduction -- 7.2 MDCT Imaging Techniques -- 7.3 MR Imaging Technique -- 7.4 Benign Hepatic Lesions -- 7.4.1 Cysts -- 7.4.2 Hemangioma. 7.4.3 Focal Nodular Hyperplasia (FNH) -- 7.4.4 Hepatocellular Adenoma -- 7.4.5 Biliary Hamartomas (von Meyenburg Complex) -- 7.4.6 Hepatic Abscess and Echinococcus -- 7.5 Malignant Primary Tumors -- 7.5.1 Hepatocellular Carcinoma -- 7.5.2 Fibrolamellar HCC -- 7.5.3 Cholangiocellular Carcinoma -- 7.6 Rare Primary Liver Tumors -- 7.6.1 Biliary Cystadenoma/Cystadenocarcinomas -- 7.6.2 Hepatic Angiosarcoma -- 7.6.3 Epithelioid Hemangioendothelioma -- 7.7 Hepatic Metastases -- 7.8 Differential Diagnosis of Focal Liver Lesions -- 7.9 Concluding Remarks -- References -- 8: Diseases of the Gallbladder and the Biliary Tree -- 8.1 Biliary Tract -- 8.1.1 Normal Anatomy and Variants -- 8.1.2 Congenital Biliary Anomalies -- 8.1.2.1 Choledochal Cysts and Anomalous Pancreatobiliary Ductal Junction -- 8.1.3 Pathologic Conditions -- 8.1.3.1 Choledocholithiasis -- 8.1.3.2 Cholangitis -- Suppurative Cholangitis -- Pyogenic Cholangitis -- Primary Sclerosing Cholangitis -- 8.1.3.3 IgG4 Cholangitis -- 8.1.3.4 Neoplasms of the Biliary System -- Benign Tumors of the Bile Ducts -- Hamartomas and adenomas -- Biliary Intraepithelial Neoplasm and Intraductal Papillary Neoplasms of the Bile Ducts -- Mucinous Cystic Neoplasms -- Malignant Tumors of the Bile Ducts -- Cholangiocarcinoma -- Metastatic Disease -- 8.2 Gallbladder -- 8.2.1 Normal Anatomy -- 8.2.2 Congenital Variants and Anomalies -- 8.2.2.1 Agenesis of the Gallbladder -- 8.2.2.2 Duplication of the Gallbladder -- 8.2.2.3 Phrygian Cap of the Gallbladder -- 8.2.2.4 Diverticula of the Gallbladder, Multiseptate Gallbladder, and Ectopic Gallbladder -- 8.2.3 Pathologic Conditions -- 8.2.3.1 Gallstones -- 8.2.3.2 Acute Cholecystitis -- 8.2.3.3 Acalculous Cholecystitis -- 8.2.3.4 Chronic Cholecystitis -- 8.2.3.5 Hyperplastic Cholecystosis -- 8.2.3.6 Gallbladder Neoplasms -- 8.3 Conclusion. References -- 9: Diseases of the Pancreas -- 9.1 Developmental Anomalies of the Pancreas -- 9.2 Pancreatic Neoplasms -- 9.2.1 Pancreatic Carcinoma -- 9.2.2 Other Tumors of Ductal Origin -- 9.3 Cystic Neoplasm -- 9.3.1 Serous Cystadenoma -- 9.3.2 Mucinous Cystic Neoplasm (MCN) -- 9.3.3 Intraductal Papillary Mucinous Neoplasm (IPMN) -- 9.4 Other Neoplasm -- 9.4.1 Neuroendocrine Tumors -- 9.4.1.1 Insulinoma -- 9.4.1.2 Gastrinoma -- 9.4.2 Other Rare Pancreatic Neoplasm -- 9.5 Inflammatory Diseases of the Pancreas -- 9.5.1 Acute and Chronic Pancreatitis -- 9.5.2 Autoimmune Pancreatitis -- References -- 10: Adrenal Diseases -- 10.1 Introduction -- 10.2 Incidental Adrenal Mass: No Underlying Malignancy -- 10.2.1 Unenhanced CT -- 10.2.2 CT Contrast-Washout -- 10.2.3 Dual Energy CT -- 10.2.4 MRI -- 10.2.5 FDG PET/CT -- 10.2.6 Lesion Morphology -- 10.2.7 Adrenal Biopsy -- 10.2.8 Management -- 10.3 Evaluation of Adrenal Mass in Patient with Known Extra-Adrenal Malignancy -- 10.4 Evaluation of Patient with Suspected Adrenal Hyperfunction -- 10.4.1 Adrenal Cortical Hyperfunction -- 10.4.2 Adrenal Medullary Hyperfunction -- 10.5 Future Directions -- 10.6 Concluding Remarks -- References -- 11: Benign and Malignant Renal Disease -- 11.1 Introduction -- 11.2 Modalities for Imaging Renal Masses -- 11.2.1 Ultrasound (US) and Contrast-Enhanced US (CEUS) -- 11.2.2 Computed Tomography (CT) and Magnetic Resonance Imaging (MRI) -- 11.3 Very Small Renal Masses (< -- 1-1.5 cm) -- 11.4 Cystic Renal Masses -- 11.5 Angiomyolipoma (AML) -- 11.6 Other Solid Renal Masses and Cancer Mimics -- 11.6.1 Oncocytomas -- 11.6.2 Renal Cell Cancers (RCCs) -- 11.6.2.1 Clear Cell Renal Cell Cancer (ccRCC) -- 11.6.2.2 Papillary Renal Cell Cancer (pRCC) -- 11.6.2.3 Chromophobe Renal Cell Cancer (chRCC) -- 11.6.2.4 Uncommon Renal Cancer Cell Types. 11.6.3 Urothelial Neoplasms and Lymphoma. Description based on publisher supplied metadata and other sources. Electronic reproduction. Ann Arbor, Michigan : ProQuest Ebook Central, 2024. Available via World Wide Web. Access may be limited to ProQuest Ebook Central affiliated libraries. Electronic books. Kubik-Huch, Rahel A. Roos, Justus E. von Schulthess, , Gustav K. Print version: Hodler, Juerg Diseases of the Abdomen and Pelvis 2023-2026 Cham : Springer International Publishing AG,c2023 9783031273544 ProQuest (Firm) https://ebookcentral.proquest.com/lib/oeawat/detail.action?docID=7216788 Click to View |
language |
English |
format |
eBook |
author |
Hodler, Juerg. |
spellingShingle |
Hodler, Juerg. Diseases of the Abdomen and Pelvis 2023-2026 : Diagnostic Imaging. IDKD Springer Series Intro -- Contents -- 1: Emergency Radiology of the Abdomen and Pelvis -- 1.1 Trauma Part -- 1.1.1 Role of Imaging to Assess Blunt Abdominal Polytrauma (BAT) Patients -- 1.1.1.1 Primary Survey -- 1.1.1.2 Secondary Survey -- Imaging of Common Abdominal Traumatic Injuries -- Intraperitoneal Fluid -- Organ Injuries -- Spleen Injuries -- Liver Injuries -- Urinary Tract Injuries -- Bowel and Mesenteric Injuries -- Diaphragmatic Injuries -- Pancreatic Injuries -- 1.2 Non-Traumatic Abdominal Pain -- 1.2.1 Modalities -- 1.2.2 Right Upper Quadrant -- 1.2.2.1 Acute Cholecystitis -- 1.2.2.2 Duodenal Ulcers -- 1.2.3 Left Upper Quadrant -- 1.2.3.1 Acute Pancreatitis -- 1.2.3.2 Gastritis -- 1.2.4 Right Lower Quadrant Pain -- 1.2.4.1 Acute Appendicitis -- 1.2.4.2 Cecal Inflammation -- 1.2.4.3 Terminal Ileitis -- 1.2.5 Left Lower Quadrant Pain -- 1.2.5.1 Sigmoid Diverticulitis -- 1.2.5.2 Epiploic Appendagitis -- 1.2.5.3 Pelvic Pain: Endometriosis -- 1.2.5.4 Ovarian Torsion -- 1.2.6 Diffuse Abdominal Pain -- 1.2.6.1 Small Bowel Obstruction -- 1.2.6.2 Colonic Obstruction -- 1.2.6.3 Acute Mesenteric Ischemia -- 1.2.7 Concluding Remarks -- References -- 2: Imaging Infectious Disease of the Abdomen (Including COVID-19) -- 2.1 Introduction -- 2.2 Risk Factors for Infections -- 2.2.1 Barrier Disruption -- 2.2.2 Anatomic Obstruction -- 2.2.3 Vascular Compromise -- 2.2.4 Pre-existing Malignancy -- 2.2.5 Immunosuppression -- 2.2.6 Prior Radiation -- 2.2.7 Medical Devices -- 2.2.8 Surgery -- 2.3 Imaging in Abdominal Infections -- 2.3.1 Gastrointestinal Tract Infections -- 2.3.1.1 Clostridioides Difficile Colitis -- 2.3.1.2 Neutropenic Enterocolitis -- 2.3.1.3 Gastrointestinal Tuberculosis -- 2.3.1.4 Viral Enterocolitis -- 2.3.1.5 Fungal Infections -- 2.3.2 Hepatobiliary Infections -- 2.3.2.1 Liver Abscesses. 2.3.2.2 Cholangitis -- 2.3.2.3 Viral Infections -- 2.3.2.4 Parasitic Infections -- 2.3.3 Genitourinary Tract Infections -- 2.3.3.1 Obstructive Uropathy -- 2.3.3.2 Renal and Urinary Bladder Infections -- 2.3.3.3 Prostatic Infections -- 2.3.4 Peritoneal and Abdominal Wall Infections -- 2.3.4.1 Peritoneal Devices -- 2.3.4.2 Intra-abdominal Abscesses -- 2.3.4.3 Abdominal Wall Infections -- 2.4 Conclusion -- References -- 3: Advances in Molecular Imaging and Therapy and Its Impact in Oncologic Imaging -- 3.1 Introduction -- 3.2 Introduction to Theranostics -- 3.2.1 Therapeutic Radionuclides -- 3.2.2 Unique Role of Dosimetry -- 3.2.3 Current Theranostic Agents and Agents in Development -- 3.2.4 Patient Selection for Internal Radiotherapy -- 3.3 Monitoring Disease -- 3.3.1 Response Based on Morphology -- 3.3.2 Response Based on Morphology for Immunotherapy -- 3.3.3 Response Based on FDG PET -- 3.4 Monitoring Liver Disease After SIRT -- 3.4.1 Monitoring SIRT with CT/MRI -- 3.4.2 Monitoring SIRT with PET -- 3.5 Monitoring Neuroendocrine Tumors -- 3.6 Monitoring Metastasized Prostate Cancer -- 3.6.1 Conventional Monitoring of Metastasized Prostate Cancer with CT and Bone Scans -- 3.6.2 Monitoring Metastasized Prostate Cancer with PET/CT -- 3.7 The Role of MRI and PET/MRI for Response Evaluation -- 3.8 Concluding Remarks -- References -- 4: Benign and Malignant Diseases of the Colon and Rectum -- 4.1 Benign Diseases of the Colon and Rectum -- 4.1.1 Inflammatory Diseases of the Colon and Rectum -- 4.1.1.1 Chronic Inflammatory Bowel Diseases -- 4.1.1.2 Infectious Colitis -- Pseudomembranous Colitis -- 4.1.1.3 Non-infectious Colitis -- Ischemic Colitis -- Drug-Induced Colitis -- Neutropenic Colitis -- Radiation Colitis and Proctitis -- Graft-Versus-Host Disease -- 4.1.2 Diverticular Disease and Diverticulitis. 4.1.3 Benign Mucosal Colonic Polyp -- 4.2 Malignant Diseases of the Colon and Rectum -- 4.2.1 Rectal Cancer -- 4.2.1.1 Elective Rectal Cancer Staging -- 4.2.2 Colon Cancer -- 4.2.2.1 Elective Colon Cancer Staging -- 4.2.2.2 Colon Cancer Presenting as Acute Abdomen -- 4.2.3 Evaluation of Response to Neoadjuvant Therapy in Rectal Cancer -- 4.2.3.1 Technique -- 4.2.3.2 Re-staging to Plan Surgery -- 4.2.3.3 The Prognostic Value of Re-staging MR Imaging -- 4.2.3.4 Re-staging to Select Patients for Non-operative Management -- 4.3 Concluding Remarks -- References -- 5: Indeterminate Retroperitoneal Masses -- 5.1 Introduction -- 5.2 Retroperitoneal Space -- 5.3 Tissue Diagnosis -- 5.4 Adipocytic Tumors -- 5.5 Other Soft-Tissue Sarcomas -- 5.6 Neurogenic Tumors -- 5.7 Miscellaneous -- 5.8 Concluding Remarks -- References -- 6: Diffuse Liver Disease -- 6.1 Metabolic and Storage Diseases -- 6.1.1 Steatosis -- 6.1.2 Iron Overload -- 6.1.3 Wilson's Disease -- 6.1.4 Amyloidosis -- 6.1.5 Gaucher Disease -- 6.2 Cirrhosis -- 6.2.1 Imaging of Pre-stages of Cirrhosis -- 6.2.2 Imaging of Cirrhosis -- 6.3 Focal Lesions in Cirrhotic Liver -- 6.3.1 Regenerative Nodules -- 6.3.2 Dysplastic Nodules -- 6.3.3 Malignant Lesions -- 6.3.4 Confluent Focal Fibrosis -- 6.3.5 Standardized Reporting with LI-RADS -- 6.4 Diffuse Vascular Liver Disease -- 6.4.1 Arteriovenous Shunts -- 6.4.2 Budd-Chiari Syndrome -- 6.4.3 Sinusoidal Obstruction Syndrome -- 6.4.4 Passive Hepatic Congestion and Fontan-Associated Liver Disease -- 6.4.5 Hereditary Hemorrhagic Telangiectasia (HHT) -- 6.5 Diffuse Metastatic Disease -- 6.6 Concluding Remarks -- References -- 7: Focal Liver Lesions -- 7.1 Introduction -- 7.2 MDCT Imaging Techniques -- 7.3 MR Imaging Technique -- 7.4 Benign Hepatic Lesions -- 7.4.1 Cysts -- 7.4.2 Hemangioma. 7.4.3 Focal Nodular Hyperplasia (FNH) -- 7.4.4 Hepatocellular Adenoma -- 7.4.5 Biliary Hamartomas (von Meyenburg Complex) -- 7.4.6 Hepatic Abscess and Echinococcus -- 7.5 Malignant Primary Tumors -- 7.5.1 Hepatocellular Carcinoma -- 7.5.2 Fibrolamellar HCC -- 7.5.3 Cholangiocellular Carcinoma -- 7.6 Rare Primary Liver Tumors -- 7.6.1 Biliary Cystadenoma/Cystadenocarcinomas -- 7.6.2 Hepatic Angiosarcoma -- 7.6.3 Epithelioid Hemangioendothelioma -- 7.7 Hepatic Metastases -- 7.8 Differential Diagnosis of Focal Liver Lesions -- 7.9 Concluding Remarks -- References -- 8: Diseases of the Gallbladder and the Biliary Tree -- 8.1 Biliary Tract -- 8.1.1 Normal Anatomy and Variants -- 8.1.2 Congenital Biliary Anomalies -- 8.1.2.1 Choledochal Cysts and Anomalous Pancreatobiliary Ductal Junction -- 8.1.3 Pathologic Conditions -- 8.1.3.1 Choledocholithiasis -- 8.1.3.2 Cholangitis -- Suppurative Cholangitis -- Pyogenic Cholangitis -- Primary Sclerosing Cholangitis -- 8.1.3.3 IgG4 Cholangitis -- 8.1.3.4 Neoplasms of the Biliary System -- Benign Tumors of the Bile Ducts -- Hamartomas and adenomas -- Biliary Intraepithelial Neoplasm and Intraductal Papillary Neoplasms of the Bile Ducts -- Mucinous Cystic Neoplasms -- Malignant Tumors of the Bile Ducts -- Cholangiocarcinoma -- Metastatic Disease -- 8.2 Gallbladder -- 8.2.1 Normal Anatomy -- 8.2.2 Congenital Variants and Anomalies -- 8.2.2.1 Agenesis of the Gallbladder -- 8.2.2.2 Duplication of the Gallbladder -- 8.2.2.3 Phrygian Cap of the Gallbladder -- 8.2.2.4 Diverticula of the Gallbladder, Multiseptate Gallbladder, and Ectopic Gallbladder -- 8.2.3 Pathologic Conditions -- 8.2.3.1 Gallstones -- 8.2.3.2 Acute Cholecystitis -- 8.2.3.3 Acalculous Cholecystitis -- 8.2.3.4 Chronic Cholecystitis -- 8.2.3.5 Hyperplastic Cholecystosis -- 8.2.3.6 Gallbladder Neoplasms -- 8.3 Conclusion. References -- 9: Diseases of the Pancreas -- 9.1 Developmental Anomalies of the Pancreas -- 9.2 Pancreatic Neoplasms -- 9.2.1 Pancreatic Carcinoma -- 9.2.2 Other Tumors of Ductal Origin -- 9.3 Cystic Neoplasm -- 9.3.1 Serous Cystadenoma -- 9.3.2 Mucinous Cystic Neoplasm (MCN) -- 9.3.3 Intraductal Papillary Mucinous Neoplasm (IPMN) -- 9.4 Other Neoplasm -- 9.4.1 Neuroendocrine Tumors -- 9.4.1.1 Insulinoma -- 9.4.1.2 Gastrinoma -- 9.4.2 Other Rare Pancreatic Neoplasm -- 9.5 Inflammatory Diseases of the Pancreas -- 9.5.1 Acute and Chronic Pancreatitis -- 9.5.2 Autoimmune Pancreatitis -- References -- 10: Adrenal Diseases -- 10.1 Introduction -- 10.2 Incidental Adrenal Mass: No Underlying Malignancy -- 10.2.1 Unenhanced CT -- 10.2.2 CT Contrast-Washout -- 10.2.3 Dual Energy CT -- 10.2.4 MRI -- 10.2.5 FDG PET/CT -- 10.2.6 Lesion Morphology -- 10.2.7 Adrenal Biopsy -- 10.2.8 Management -- 10.3 Evaluation of Adrenal Mass in Patient with Known Extra-Adrenal Malignancy -- 10.4 Evaluation of Patient with Suspected Adrenal Hyperfunction -- 10.4.1 Adrenal Cortical Hyperfunction -- 10.4.2 Adrenal Medullary Hyperfunction -- 10.5 Future Directions -- 10.6 Concluding Remarks -- References -- 11: Benign and Malignant Renal Disease -- 11.1 Introduction -- 11.2 Modalities for Imaging Renal Masses -- 11.2.1 Ultrasound (US) and Contrast-Enhanced US (CEUS) -- 11.2.2 Computed Tomography (CT) and Magnetic Resonance Imaging (MRI) -- 11.3 Very Small Renal Masses (< -- 1-1.5 cm) -- 11.4 Cystic Renal Masses -- 11.5 Angiomyolipoma (AML) -- 11.6 Other Solid Renal Masses and Cancer Mimics -- 11.6.1 Oncocytomas -- 11.6.2 Renal Cell Cancers (RCCs) -- 11.6.2.1 Clear Cell Renal Cell Cancer (ccRCC) -- 11.6.2.2 Papillary Renal Cell Cancer (pRCC) -- 11.6.2.3 Chromophobe Renal Cell Cancer (chRCC) -- 11.6.2.4 Uncommon Renal Cancer Cell Types. 11.6.3 Urothelial Neoplasms and Lymphoma. |
author_facet |
Hodler, Juerg. Kubik-Huch, Rahel A. Roos, Justus E. von Schulthess, , Gustav K. |
author_variant |
j h jh |
author2 |
Kubik-Huch, Rahel A. Roos, Justus E. von Schulthess, , Gustav K. |
author2_variant |
r a k h rak rakh j e r je jer s g k v sgk sgkv |
author2_role |
TeilnehmendeR TeilnehmendeR TeilnehmendeR |
author_sort |
Hodler, Juerg. |
title |
Diseases of the Abdomen and Pelvis 2023-2026 : Diagnostic Imaging. |
title_sub |
Diagnostic Imaging. |
title_full |
Diseases of the Abdomen and Pelvis 2023-2026 : Diagnostic Imaging. |
title_fullStr |
Diseases of the Abdomen and Pelvis 2023-2026 : Diagnostic Imaging. |
title_full_unstemmed |
Diseases of the Abdomen and Pelvis 2023-2026 : Diagnostic Imaging. |
title_auth |
Diseases of the Abdomen and Pelvis 2023-2026 : Diagnostic Imaging. |
title_new |
Diseases of the Abdomen and Pelvis 2023-2026 : |
title_sort |
diseases of the abdomen and pelvis 2023-2026 : diagnostic imaging. |
series |
IDKD Springer Series |
series2 |
IDKD Springer Series |
publisher |
Springer International Publishing AG, |
publishDate |
2023 |
physical |
1 online resource (287 pages) |
edition |
1st ed. |
contents |
Intro -- Contents -- 1: Emergency Radiology of the Abdomen and Pelvis -- 1.1 Trauma Part -- 1.1.1 Role of Imaging to Assess Blunt Abdominal Polytrauma (BAT) Patients -- 1.1.1.1 Primary Survey -- 1.1.1.2 Secondary Survey -- Imaging of Common Abdominal Traumatic Injuries -- Intraperitoneal Fluid -- Organ Injuries -- Spleen Injuries -- Liver Injuries -- Urinary Tract Injuries -- Bowel and Mesenteric Injuries -- Diaphragmatic Injuries -- Pancreatic Injuries -- 1.2 Non-Traumatic Abdominal Pain -- 1.2.1 Modalities -- 1.2.2 Right Upper Quadrant -- 1.2.2.1 Acute Cholecystitis -- 1.2.2.2 Duodenal Ulcers -- 1.2.3 Left Upper Quadrant -- 1.2.3.1 Acute Pancreatitis -- 1.2.3.2 Gastritis -- 1.2.4 Right Lower Quadrant Pain -- 1.2.4.1 Acute Appendicitis -- 1.2.4.2 Cecal Inflammation -- 1.2.4.3 Terminal Ileitis -- 1.2.5 Left Lower Quadrant Pain -- 1.2.5.1 Sigmoid Diverticulitis -- 1.2.5.2 Epiploic Appendagitis -- 1.2.5.3 Pelvic Pain: Endometriosis -- 1.2.5.4 Ovarian Torsion -- 1.2.6 Diffuse Abdominal Pain -- 1.2.6.1 Small Bowel Obstruction -- 1.2.6.2 Colonic Obstruction -- 1.2.6.3 Acute Mesenteric Ischemia -- 1.2.7 Concluding Remarks -- References -- 2: Imaging Infectious Disease of the Abdomen (Including COVID-19) -- 2.1 Introduction -- 2.2 Risk Factors for Infections -- 2.2.1 Barrier Disruption -- 2.2.2 Anatomic Obstruction -- 2.2.3 Vascular Compromise -- 2.2.4 Pre-existing Malignancy -- 2.2.5 Immunosuppression -- 2.2.6 Prior Radiation -- 2.2.7 Medical Devices -- 2.2.8 Surgery -- 2.3 Imaging in Abdominal Infections -- 2.3.1 Gastrointestinal Tract Infections -- 2.3.1.1 Clostridioides Difficile Colitis -- 2.3.1.2 Neutropenic Enterocolitis -- 2.3.1.3 Gastrointestinal Tuberculosis -- 2.3.1.4 Viral Enterocolitis -- 2.3.1.5 Fungal Infections -- 2.3.2 Hepatobiliary Infections -- 2.3.2.1 Liver Abscesses. 2.3.2.2 Cholangitis -- 2.3.2.3 Viral Infections -- 2.3.2.4 Parasitic Infections -- 2.3.3 Genitourinary Tract Infections -- 2.3.3.1 Obstructive Uropathy -- 2.3.3.2 Renal and Urinary Bladder Infections -- 2.3.3.3 Prostatic Infections -- 2.3.4 Peritoneal and Abdominal Wall Infections -- 2.3.4.1 Peritoneal Devices -- 2.3.4.2 Intra-abdominal Abscesses -- 2.3.4.3 Abdominal Wall Infections -- 2.4 Conclusion -- References -- 3: Advances in Molecular Imaging and Therapy and Its Impact in Oncologic Imaging -- 3.1 Introduction -- 3.2 Introduction to Theranostics -- 3.2.1 Therapeutic Radionuclides -- 3.2.2 Unique Role of Dosimetry -- 3.2.3 Current Theranostic Agents and Agents in Development -- 3.2.4 Patient Selection for Internal Radiotherapy -- 3.3 Monitoring Disease -- 3.3.1 Response Based on Morphology -- 3.3.2 Response Based on Morphology for Immunotherapy -- 3.3.3 Response Based on FDG PET -- 3.4 Monitoring Liver Disease After SIRT -- 3.4.1 Monitoring SIRT with CT/MRI -- 3.4.2 Monitoring SIRT with PET -- 3.5 Monitoring Neuroendocrine Tumors -- 3.6 Monitoring Metastasized Prostate Cancer -- 3.6.1 Conventional Monitoring of Metastasized Prostate Cancer with CT and Bone Scans -- 3.6.2 Monitoring Metastasized Prostate Cancer with PET/CT -- 3.7 The Role of MRI and PET/MRI for Response Evaluation -- 3.8 Concluding Remarks -- References -- 4: Benign and Malignant Diseases of the Colon and Rectum -- 4.1 Benign Diseases of the Colon and Rectum -- 4.1.1 Inflammatory Diseases of the Colon and Rectum -- 4.1.1.1 Chronic Inflammatory Bowel Diseases -- 4.1.1.2 Infectious Colitis -- Pseudomembranous Colitis -- 4.1.1.3 Non-infectious Colitis -- Ischemic Colitis -- Drug-Induced Colitis -- Neutropenic Colitis -- Radiation Colitis and Proctitis -- Graft-Versus-Host Disease -- 4.1.2 Diverticular Disease and Diverticulitis. 4.1.3 Benign Mucosal Colonic Polyp -- 4.2 Malignant Diseases of the Colon and Rectum -- 4.2.1 Rectal Cancer -- 4.2.1.1 Elective Rectal Cancer Staging -- 4.2.2 Colon Cancer -- 4.2.2.1 Elective Colon Cancer Staging -- 4.2.2.2 Colon Cancer Presenting as Acute Abdomen -- 4.2.3 Evaluation of Response to Neoadjuvant Therapy in Rectal Cancer -- 4.2.3.1 Technique -- 4.2.3.2 Re-staging to Plan Surgery -- 4.2.3.3 The Prognostic Value of Re-staging MR Imaging -- 4.2.3.4 Re-staging to Select Patients for Non-operative Management -- 4.3 Concluding Remarks -- References -- 5: Indeterminate Retroperitoneal Masses -- 5.1 Introduction -- 5.2 Retroperitoneal Space -- 5.3 Tissue Diagnosis -- 5.4 Adipocytic Tumors -- 5.5 Other Soft-Tissue Sarcomas -- 5.6 Neurogenic Tumors -- 5.7 Miscellaneous -- 5.8 Concluding Remarks -- References -- 6: Diffuse Liver Disease -- 6.1 Metabolic and Storage Diseases -- 6.1.1 Steatosis -- 6.1.2 Iron Overload -- 6.1.3 Wilson's Disease -- 6.1.4 Amyloidosis -- 6.1.5 Gaucher Disease -- 6.2 Cirrhosis -- 6.2.1 Imaging of Pre-stages of Cirrhosis -- 6.2.2 Imaging of Cirrhosis -- 6.3 Focal Lesions in Cirrhotic Liver -- 6.3.1 Regenerative Nodules -- 6.3.2 Dysplastic Nodules -- 6.3.3 Malignant Lesions -- 6.3.4 Confluent Focal Fibrosis -- 6.3.5 Standardized Reporting with LI-RADS -- 6.4 Diffuse Vascular Liver Disease -- 6.4.1 Arteriovenous Shunts -- 6.4.2 Budd-Chiari Syndrome -- 6.4.3 Sinusoidal Obstruction Syndrome -- 6.4.4 Passive Hepatic Congestion and Fontan-Associated Liver Disease -- 6.4.5 Hereditary Hemorrhagic Telangiectasia (HHT) -- 6.5 Diffuse Metastatic Disease -- 6.6 Concluding Remarks -- References -- 7: Focal Liver Lesions -- 7.1 Introduction -- 7.2 MDCT Imaging Techniques -- 7.3 MR Imaging Technique -- 7.4 Benign Hepatic Lesions -- 7.4.1 Cysts -- 7.4.2 Hemangioma. 7.4.3 Focal Nodular Hyperplasia (FNH) -- 7.4.4 Hepatocellular Adenoma -- 7.4.5 Biliary Hamartomas (von Meyenburg Complex) -- 7.4.6 Hepatic Abscess and Echinococcus -- 7.5 Malignant Primary Tumors -- 7.5.1 Hepatocellular Carcinoma -- 7.5.2 Fibrolamellar HCC -- 7.5.3 Cholangiocellular Carcinoma -- 7.6 Rare Primary Liver Tumors -- 7.6.1 Biliary Cystadenoma/Cystadenocarcinomas -- 7.6.2 Hepatic Angiosarcoma -- 7.6.3 Epithelioid Hemangioendothelioma -- 7.7 Hepatic Metastases -- 7.8 Differential Diagnosis of Focal Liver Lesions -- 7.9 Concluding Remarks -- References -- 8: Diseases of the Gallbladder and the Biliary Tree -- 8.1 Biliary Tract -- 8.1.1 Normal Anatomy and Variants -- 8.1.2 Congenital Biliary Anomalies -- 8.1.2.1 Choledochal Cysts and Anomalous Pancreatobiliary Ductal Junction -- 8.1.3 Pathologic Conditions -- 8.1.3.1 Choledocholithiasis -- 8.1.3.2 Cholangitis -- Suppurative Cholangitis -- Pyogenic Cholangitis -- Primary Sclerosing Cholangitis -- 8.1.3.3 IgG4 Cholangitis -- 8.1.3.4 Neoplasms of the Biliary System -- Benign Tumors of the Bile Ducts -- Hamartomas and adenomas -- Biliary Intraepithelial Neoplasm and Intraductal Papillary Neoplasms of the Bile Ducts -- Mucinous Cystic Neoplasms -- Malignant Tumors of the Bile Ducts -- Cholangiocarcinoma -- Metastatic Disease -- 8.2 Gallbladder -- 8.2.1 Normal Anatomy -- 8.2.2 Congenital Variants and Anomalies -- 8.2.2.1 Agenesis of the Gallbladder -- 8.2.2.2 Duplication of the Gallbladder -- 8.2.2.3 Phrygian Cap of the Gallbladder -- 8.2.2.4 Diverticula of the Gallbladder, Multiseptate Gallbladder, and Ectopic Gallbladder -- 8.2.3 Pathologic Conditions -- 8.2.3.1 Gallstones -- 8.2.3.2 Acute Cholecystitis -- 8.2.3.3 Acalculous Cholecystitis -- 8.2.3.4 Chronic Cholecystitis -- 8.2.3.5 Hyperplastic Cholecystosis -- 8.2.3.6 Gallbladder Neoplasms -- 8.3 Conclusion. References -- 9: Diseases of the Pancreas -- 9.1 Developmental Anomalies of the Pancreas -- 9.2 Pancreatic Neoplasms -- 9.2.1 Pancreatic Carcinoma -- 9.2.2 Other Tumors of Ductal Origin -- 9.3 Cystic Neoplasm -- 9.3.1 Serous Cystadenoma -- 9.3.2 Mucinous Cystic Neoplasm (MCN) -- 9.3.3 Intraductal Papillary Mucinous Neoplasm (IPMN) -- 9.4 Other Neoplasm -- 9.4.1 Neuroendocrine Tumors -- 9.4.1.1 Insulinoma -- 9.4.1.2 Gastrinoma -- 9.4.2 Other Rare Pancreatic Neoplasm -- 9.5 Inflammatory Diseases of the Pancreas -- 9.5.1 Acute and Chronic Pancreatitis -- 9.5.2 Autoimmune Pancreatitis -- References -- 10: Adrenal Diseases -- 10.1 Introduction -- 10.2 Incidental Adrenal Mass: No Underlying Malignancy -- 10.2.1 Unenhanced CT -- 10.2.2 CT Contrast-Washout -- 10.2.3 Dual Energy CT -- 10.2.4 MRI -- 10.2.5 FDG PET/CT -- 10.2.6 Lesion Morphology -- 10.2.7 Adrenal Biopsy -- 10.2.8 Management -- 10.3 Evaluation of Adrenal Mass in Patient with Known Extra-Adrenal Malignancy -- 10.4 Evaluation of Patient with Suspected Adrenal Hyperfunction -- 10.4.1 Adrenal Cortical Hyperfunction -- 10.4.2 Adrenal Medullary Hyperfunction -- 10.5 Future Directions -- 10.6 Concluding Remarks -- References -- 11: Benign and Malignant Renal Disease -- 11.1 Introduction -- 11.2 Modalities for Imaging Renal Masses -- 11.2.1 Ultrasound (US) and Contrast-Enhanced US (CEUS) -- 11.2.2 Computed Tomography (CT) and Magnetic Resonance Imaging (MRI) -- 11.3 Very Small Renal Masses (< -- 1-1.5 cm) -- 11.4 Cystic Renal Masses -- 11.5 Angiomyolipoma (AML) -- 11.6 Other Solid Renal Masses and Cancer Mimics -- 11.6.1 Oncocytomas -- 11.6.2 Renal Cell Cancers (RCCs) -- 11.6.2.1 Clear Cell Renal Cell Cancer (ccRCC) -- 11.6.2.2 Papillary Renal Cell Cancer (pRCC) -- 11.6.2.3 Chromophobe Renal Cell Cancer (chRCC) -- 11.6.2.4 Uncommon Renal Cancer Cell Types. 11.6.3 Urothelial Neoplasms and Lymphoma. |
isbn |
9783031273551 9783031273544 |
callnumber-first |
R - Medicine |
callnumber-subject |
R - General Medicine |
callnumber-label |
R895-920 |
callnumber-sort |
R 3895 3920 |
genre |
Electronic books. |
genre_facet |
Electronic books. |
url |
https://ebookcentral.proquest.com/lib/oeawat/detail.action?docID=7216788 |
illustrated |
Not Illustrated |
oclc_num |
1373693615 |
work_keys_str_mv |
AT hodlerjuerg diseasesoftheabdomenandpelvis20232026diagnosticimaging AT kubikhuchrahela diseasesoftheabdomenandpelvis20232026diagnosticimaging AT roosjustuse diseasesoftheabdomenandpelvis20232026diagnosticimaging AT vonschulthessgustavk diseasesoftheabdomenandpelvis20232026diagnosticimaging |
status_str |
n |
ids_txt_mv |
(MiAaPQ)5007216788 (Au-PeEL)EBL7216788 (OCoLC)1373693615 |
carrierType_str_mv |
cr |
hierarchy_parent_title |
IDKD Springer Series |
is_hierarchy_title |
Diseases of the Abdomen and Pelvis 2023-2026 : Diagnostic Imaging. |
container_title |
IDKD Springer Series |
author2_original_writing_str_mv |
noLinkedField noLinkedField noLinkedField |
marc_error |
Info : MARC8 translation shorter than ISO-8859-1, choosing MARC8. --- [ 856 : z ] |
_version_ |
1792331065871826944 |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>11703nam a22004933i 4500</leader><controlfield tag="001">5007216788</controlfield><controlfield tag="003">MiAaPQ</controlfield><controlfield tag="005">20240229073848.0</controlfield><controlfield tag="006">m o d | </controlfield><controlfield tag="007">cr cnu||||||||</controlfield><controlfield tag="008">240229s2023 xx o ||||0 eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9783031273551</subfield><subfield code="q">(electronic bk.)</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="z">9783031273544</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(MiAaPQ)5007216788</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(Au-PeEL)EBL7216788</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1373693615</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">MiAaPQ</subfield><subfield code="b">eng</subfield><subfield code="e">rda</subfield><subfield code="e">pn</subfield><subfield code="c">MiAaPQ</subfield><subfield code="d">MiAaPQ</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">R895-920</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Hodler, Juerg.</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Diseases of the Abdomen and Pelvis 2023-2026 :</subfield><subfield code="b">Diagnostic Imaging.</subfield></datafield><datafield tag="250" ind1=" " ind2=" "><subfield code="a">1st ed.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Cham :</subfield><subfield code="b">Springer International Publishing AG,</subfield><subfield code="c">2023.</subfield></datafield><datafield tag="264" ind1=" " ind2="4"><subfield code="c">©2023.</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (287 pages)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">IDKD Springer Series</subfield></datafield><datafield tag="505" ind1="0" ind2=" "><subfield code="a">Intro -- Contents -- 1: Emergency Radiology of the Abdomen and Pelvis -- 1.1 Trauma Part -- 1.1.1 Role of Imaging to Assess Blunt Abdominal Polytrauma (BAT) Patients -- 1.1.1.1 Primary Survey -- 1.1.1.2 Secondary Survey -- Imaging of Common Abdominal Traumatic Injuries -- Intraperitoneal Fluid -- Organ Injuries -- Spleen Injuries -- Liver Injuries -- Urinary Tract Injuries -- Bowel and Mesenteric Injuries -- Diaphragmatic Injuries -- Pancreatic Injuries -- 1.2 Non-Traumatic Abdominal Pain -- 1.2.1 Modalities -- 1.2.2 Right Upper Quadrant -- 1.2.2.1 Acute Cholecystitis -- 1.2.2.2 Duodenal Ulcers -- 1.2.3 Left Upper Quadrant -- 1.2.3.1 Acute Pancreatitis -- 1.2.3.2 Gastritis -- 1.2.4 Right Lower Quadrant Pain -- 1.2.4.1 Acute Appendicitis -- 1.2.4.2 Cecal Inflammation -- 1.2.4.3 Terminal Ileitis -- 1.2.5 Left Lower Quadrant Pain -- 1.2.5.1 Sigmoid Diverticulitis -- 1.2.5.2 Epiploic Appendagitis -- 1.2.5.3 Pelvic Pain: Endometriosis -- 1.2.5.4 Ovarian Torsion -- 1.2.6 Diffuse Abdominal Pain -- 1.2.6.1 Small Bowel Obstruction -- 1.2.6.2 Colonic Obstruction -- 1.2.6.3 Acute Mesenteric Ischemia -- 1.2.7 Concluding Remarks -- References -- 2: Imaging Infectious Disease of the Abdomen (Including COVID-19) -- 2.1 Introduction -- 2.2 Risk Factors for Infections -- 2.2.1 Barrier Disruption -- 2.2.2 Anatomic Obstruction -- 2.2.3 Vascular Compromise -- 2.2.4 Pre-existing Malignancy -- 2.2.5 Immunosuppression -- 2.2.6 Prior Radiation -- 2.2.7 Medical Devices -- 2.2.8 Surgery -- 2.3 Imaging in Abdominal Infections -- 2.3.1 Gastrointestinal Tract Infections -- 2.3.1.1 Clostridioides Difficile Colitis -- 2.3.1.2 Neutropenic Enterocolitis -- 2.3.1.3 Gastrointestinal Tuberculosis -- 2.3.1.4 Viral Enterocolitis -- 2.3.1.5 Fungal Infections -- 2.3.2 Hepatobiliary Infections -- 2.3.2.1 Liver Abscesses.</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">2.3.2.2 Cholangitis -- 2.3.2.3 Viral Infections -- 2.3.2.4 Parasitic Infections -- 2.3.3 Genitourinary Tract Infections -- 2.3.3.1 Obstructive Uropathy -- 2.3.3.2 Renal and Urinary Bladder Infections -- 2.3.3.3 Prostatic Infections -- 2.3.4 Peritoneal and Abdominal Wall Infections -- 2.3.4.1 Peritoneal Devices -- 2.3.4.2 Intra-abdominal Abscesses -- 2.3.4.3 Abdominal Wall Infections -- 2.4 Conclusion -- References -- 3: Advances in Molecular Imaging and Therapy and Its Impact in Oncologic Imaging -- 3.1 Introduction -- 3.2 Introduction to Theranostics -- 3.2.1 Therapeutic Radionuclides -- 3.2.2 Unique Role of Dosimetry -- 3.2.3 Current Theranostic Agents and Agents in Development -- 3.2.4 Patient Selection for Internal Radiotherapy -- 3.3 Monitoring Disease -- 3.3.1 Response Based on Morphology -- 3.3.2 Response Based on Morphology for Immunotherapy -- 3.3.3 Response Based on FDG PET -- 3.4 Monitoring Liver Disease After SIRT -- 3.4.1 Monitoring SIRT with CT/MRI -- 3.4.2 Monitoring SIRT with PET -- 3.5 Monitoring Neuroendocrine Tumors -- 3.6 Monitoring Metastasized Prostate Cancer -- 3.6.1 Conventional Monitoring of Metastasized Prostate Cancer with CT and Bone Scans -- 3.6.2 Monitoring Metastasized Prostate Cancer with PET/CT -- 3.7 The Role of MRI and PET/MRI for Response Evaluation -- 3.8 Concluding Remarks -- References -- 4: Benign and Malignant Diseases of the Colon and Rectum -- 4.1 Benign Diseases of the Colon and Rectum -- 4.1.1 Inflammatory Diseases of the Colon and Rectum -- 4.1.1.1 Chronic Inflammatory Bowel Diseases -- 4.1.1.2 Infectious Colitis -- Pseudomembranous Colitis -- 4.1.1.3 Non-infectious Colitis -- Ischemic Colitis -- Drug-Induced Colitis -- Neutropenic Colitis -- Radiation Colitis and Proctitis -- Graft-Versus-Host Disease -- 4.1.2 Diverticular Disease and Diverticulitis.</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">4.1.3 Benign Mucosal Colonic Polyp -- 4.2 Malignant Diseases of the Colon and Rectum -- 4.2.1 Rectal Cancer -- 4.2.1.1 Elective Rectal Cancer Staging -- 4.2.2 Colon Cancer -- 4.2.2.1 Elective Colon Cancer Staging -- 4.2.2.2 Colon Cancer Presenting as Acute Abdomen -- 4.2.3 Evaluation of Response to Neoadjuvant Therapy in Rectal Cancer -- 4.2.3.1 Technique -- 4.2.3.2 Re-staging to Plan Surgery -- 4.2.3.3 The Prognostic Value of Re-staging MR Imaging -- 4.2.3.4 Re-staging to Select Patients for Non-operative Management -- 4.3 Concluding Remarks -- References -- 5: Indeterminate Retroperitoneal Masses -- 5.1 Introduction -- 5.2 Retroperitoneal Space -- 5.3 Tissue Diagnosis -- 5.4 Adipocytic Tumors -- 5.5 Other Soft-Tissue Sarcomas -- 5.6 Neurogenic Tumors -- 5.7 Miscellaneous -- 5.8 Concluding Remarks -- References -- 6: Diffuse Liver Disease -- 6.1 Metabolic and Storage Diseases -- 6.1.1 Steatosis -- 6.1.2 Iron Overload -- 6.1.3 Wilson's Disease -- 6.1.4 Amyloidosis -- 6.1.5 Gaucher Disease -- 6.2 Cirrhosis -- 6.2.1 Imaging of Pre-stages of Cirrhosis -- 6.2.2 Imaging of Cirrhosis -- 6.3 Focal Lesions in Cirrhotic Liver -- 6.3.1 Regenerative Nodules -- 6.3.2 Dysplastic Nodules -- 6.3.3 Malignant Lesions -- 6.3.4 Confluent Focal Fibrosis -- 6.3.5 Standardized Reporting with LI-RADS -- 6.4 Diffuse Vascular Liver Disease -- 6.4.1 Arteriovenous Shunts -- 6.4.2 Budd-Chiari Syndrome -- 6.4.3 Sinusoidal Obstruction Syndrome -- 6.4.4 Passive Hepatic Congestion and Fontan-Associated Liver Disease -- 6.4.5 Hereditary Hemorrhagic Telangiectasia (HHT) -- 6.5 Diffuse Metastatic Disease -- 6.6 Concluding Remarks -- References -- 7: Focal Liver Lesions -- 7.1 Introduction -- 7.2 MDCT Imaging Techniques -- 7.3 MR Imaging Technique -- 7.4 Benign Hepatic Lesions -- 7.4.1 Cysts -- 7.4.2 Hemangioma.</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">7.4.3 Focal Nodular Hyperplasia (FNH) -- 7.4.4 Hepatocellular Adenoma -- 7.4.5 Biliary Hamartomas (von Meyenburg Complex) -- 7.4.6 Hepatic Abscess and Echinococcus -- 7.5 Malignant Primary Tumors -- 7.5.1 Hepatocellular Carcinoma -- 7.5.2 Fibrolamellar HCC -- 7.5.3 Cholangiocellular Carcinoma -- 7.6 Rare Primary Liver Tumors -- 7.6.1 Biliary Cystadenoma/Cystadenocarcinomas -- 7.6.2 Hepatic Angiosarcoma -- 7.6.3 Epithelioid Hemangioendothelioma -- 7.7 Hepatic Metastases -- 7.8 Differential Diagnosis of Focal Liver Lesions -- 7.9 Concluding Remarks -- References -- 8: Diseases of the Gallbladder and the Biliary Tree -- 8.1 Biliary Tract -- 8.1.1 Normal Anatomy and Variants -- 8.1.2 Congenital Biliary Anomalies -- 8.1.2.1 Choledochal Cysts and Anomalous Pancreatobiliary Ductal Junction -- 8.1.3 Pathologic Conditions -- 8.1.3.1 Choledocholithiasis -- 8.1.3.2 Cholangitis -- Suppurative Cholangitis -- Pyogenic Cholangitis -- Primary Sclerosing Cholangitis -- 8.1.3.3 IgG4 Cholangitis -- 8.1.3.4 Neoplasms of the Biliary System -- Benign Tumors of the Bile Ducts -- Hamartomas and adenomas -- Biliary Intraepithelial Neoplasm and Intraductal Papillary Neoplasms of the Bile Ducts -- Mucinous Cystic Neoplasms -- Malignant Tumors of the Bile Ducts -- Cholangiocarcinoma -- Metastatic Disease -- 8.2 Gallbladder -- 8.2.1 Normal Anatomy -- 8.2.2 Congenital Variants and Anomalies -- 8.2.2.1 Agenesis of the Gallbladder -- 8.2.2.2 Duplication of the Gallbladder -- 8.2.2.3 Phrygian Cap of the Gallbladder -- 8.2.2.4 Diverticula of the Gallbladder, Multiseptate Gallbladder, and Ectopic Gallbladder -- 8.2.3 Pathologic Conditions -- 8.2.3.1 Gallstones -- 8.2.3.2 Acute Cholecystitis -- 8.2.3.3 Acalculous Cholecystitis -- 8.2.3.4 Chronic Cholecystitis -- 8.2.3.5 Hyperplastic Cholecystosis -- 8.2.3.6 Gallbladder Neoplasms -- 8.3 Conclusion.</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">References -- 9: Diseases of the Pancreas -- 9.1 Developmental Anomalies of the Pancreas -- 9.2 Pancreatic Neoplasms -- 9.2.1 Pancreatic Carcinoma -- 9.2.2 Other Tumors of Ductal Origin -- 9.3 Cystic Neoplasm -- 9.3.1 Serous Cystadenoma -- 9.3.2 Mucinous Cystic Neoplasm (MCN) -- 9.3.3 Intraductal Papillary Mucinous Neoplasm (IPMN) -- 9.4 Other Neoplasm -- 9.4.1 Neuroendocrine Tumors -- 9.4.1.1 Insulinoma -- 9.4.1.2 Gastrinoma -- 9.4.2 Other Rare Pancreatic Neoplasm -- 9.5 Inflammatory Diseases of the Pancreas -- 9.5.1 Acute and Chronic Pancreatitis -- 9.5.2 Autoimmune Pancreatitis -- References -- 10: Adrenal Diseases -- 10.1 Introduction -- 10.2 Incidental Adrenal Mass: No Underlying Malignancy -- 10.2.1 Unenhanced CT -- 10.2.2 CT Contrast-Washout -- 10.2.3 Dual Energy CT -- 10.2.4 MRI -- 10.2.5 FDG PET/CT -- 10.2.6 Lesion Morphology -- 10.2.7 Adrenal Biopsy -- 10.2.8 Management -- 10.3 Evaluation of Adrenal Mass in Patient with Known Extra-Adrenal Malignancy -- 10.4 Evaluation of Patient with Suspected Adrenal Hyperfunction -- 10.4.1 Adrenal Cortical Hyperfunction -- 10.4.2 Adrenal Medullary Hyperfunction -- 10.5 Future Directions -- 10.6 Concluding Remarks -- References -- 11: Benign and Malignant Renal Disease -- 11.1 Introduction -- 11.2 Modalities for Imaging Renal Masses -- 11.2.1 Ultrasound (US) and Contrast-Enhanced US (CEUS) -- 11.2.2 Computed Tomography (CT) and Magnetic Resonance Imaging (MRI) -- 11.3 Very Small Renal Masses (&lt -- 1-1.5 cm) -- 11.4 Cystic Renal Masses -- 11.5 Angiomyolipoma (AML) -- 11.6 Other Solid Renal Masses and Cancer Mimics -- 11.6.1 Oncocytomas -- 11.6.2 Renal Cell Cancers (RCCs) -- 11.6.2.1 Clear Cell Renal Cell Cancer (ccRCC) -- 11.6.2.2 Papillary Renal Cell Cancer (pRCC) -- 11.6.2.3 Chromophobe Renal Cell Cancer (chRCC) -- 11.6.2.4 Uncommon Renal Cancer Cell Types.</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">11.6.3 Urothelial Neoplasms and Lymphoma.</subfield></datafield><datafield tag="588" ind1=" " ind2=" "><subfield code="a">Description based on publisher supplied metadata and other sources.</subfield></datafield><datafield tag="590" ind1=" " ind2=" "><subfield code="a">Electronic reproduction. Ann Arbor, Michigan : ProQuest Ebook Central, 2024. Available via World Wide Web. Access may be limited to ProQuest Ebook Central affiliated libraries. </subfield></datafield><datafield tag="655" ind1=" " ind2="4"><subfield code="a">Electronic books.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kubik-Huch, Rahel A.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Roos, Justus E.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">von Schulthess, , Gustav K.</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Print version:</subfield><subfield code="a">Hodler, Juerg</subfield><subfield code="t">Diseases of the Abdomen and Pelvis 2023-2026</subfield><subfield code="d">Cham : Springer International Publishing AG,c2023</subfield><subfield code="z">9783031273544</subfield></datafield><datafield tag="797" ind1="2" ind2=" "><subfield code="a">ProQuest (Firm)</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">IDKD Springer Series</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://ebookcentral.proquest.com/lib/oeawat/detail.action?docID=7216788</subfield><subfield code="z">Click to View</subfield></datafield></record></collection> |